Updated: Oct 26, 2021 10:59 IST
Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
Read more
हिंदी खबर